4//SEC Filing
Alder Matthias 4
Accession 0001209191-23-050379
CIK 0001819411other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:34 PM ET
Size
7.2 KB
Accession
0001209191-23-050379
Insider Transaction Report
Form 4
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-09-20−2,550→ 7,650 total→ Common Stock (2,550 underlying) - Exercise/Conversion
Common Stock
2023-09-20+2,550→ 5,850 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001370820
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:34 PM ET
- Size
- 7.2 KB